Amgen Inc Profit Margin
Data as of August 04, 2026
Profit Margin (TTM)
21.0%
Revenue (TTM)
$36.93B
Sector
Biotechnology
Ticker
AMGN
How It's Calculated
What This Means
Amgen Inc's profit margin of 21.0% is solid for many industries, though norms vary widely in Biotechnology.
About Amgen Inc
Amgen Inc (AMGN) operates in the Biotechnology sector, specifically in Biotechnology. With a market capitalization of about $207.87B, it ranks as a mega-cap stock — one of the largest publicly traded companies.
Shares recently traded near $378.87, within a 52-week range of $269.77 to $398.00 (-4.8% from the high, +40.4% from the low). Beta of 0.42 indicates relatively lower volatility versus the market.
Trailing profit margin is about 21.0%, signaling a solid profit margin for its industry.
Understanding This Metric
Profit margin connects income-statement quality to valuation. For Amgen Inc, trailing margin summarizes how much revenue converts to net profit after costs. In Biotechnology, margins differ by business model — software and services often run higher margins than capital-intensive industries. Track margin trends across quarters; a stable or improving margin can support earnings durability, while sharp declines may warrant deeper review of guidance and competition.
Using This Number in Practice
At about 21.0% trailing profit margin, Amgen Inc (AMGN) suggests strong pricing power or cost discipline versus many large-cap peers. For large revenue bases, even a one-point margin move can shift earnings materially, so trend matters as much as the spot reading.
When comparing AMGN to alternatives, combine margin with return on equity, revenue growth, and valuation. Use our margin calculator for scenario work, and browse the AMGN metrics hub plus sector peers in the comparison section above.
Sector Comparison
Among Biotechnology names on our S&P 100 coverage, Amgen Inc's profit margin of 21.0% can be compared with peers such as GILD (31.0%), REGN (29.6%). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Biotechnology stocks.
Key Takeaways
- AMGN is grouped in the Biotechnology sector for peer comparisons.
- Recent beta of 0.42 suggests lower-than-market price sensitivity.
- Trailing profit margin of 21.0% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for AMGN.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Other AMGN Metrics
Frequently Asked Questions
What is AMGN's profit margin?
Trailing profit margin measures net income as a percent of revenue. Amgen Inc's margin is about 21.0% on this snapshot — higher margins often support stronger valuation multiples in Biotechnology.
Is 21.0% strong for Biotechnology?
Peers in Biotechnology such as GILD (31.0%), REGN (29.6%) help benchmark AMGN's 21.0%. Margins vary by sub-industry and accounting cycle.
How often is profit margin updated?
Margins update after quarterly earnings; price-only fields refresh on trading days. Data as of August 04, 2026.
Calculate the profit margin for any stock with our free calculator.
Open Margin Calculator →